These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12462391)

  • 1. Complement receptors in HIV infection.
    Doepper S; Kacani L; Falkensammer B; Dierich MP; Stoiber H
    Curr Mol Med; 2002 Dec; 2(8):703-11. PubMed ID: 12462391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of complement in the control of HIV dynamics and pathogenesis.
    Stoiber H; Speth C; Dierich MP
    Vaccine; 2003 Jun; 21 Suppl 2():S77-82. PubMed ID: 12763687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
    Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
    J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of complement activation on platelets.
    Devine DV
    Curr Top Microbiol Immunol; 1992; 178():101-13. PubMed ID: 1330445
    [No Abstract]   [Full Text] [Related]  

  • 5. The supportive role of complement in HIV pathogenesis.
    Stoiber H; Kacani L; Speth C; Würzner R; Dierich MP
    Immunol Rev; 2001 Apr; 180():168-76. PubMed ID: 11414359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of complement in HIV infection.
    Stoiber H; Clivio A; Dierich MP
    Annu Rev Immunol; 1997; 15():649-74. PubMed ID: 9143703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes.
    Marquart HV; Svehag SE; Leslie RG
    J Immunol; 1994 Jul; 153(1):307-15. PubMed ID: 7515925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism(s) promoting HIV-1 infection of primary unstimulated T lymphocytes in autologous B cell/T cell co-cultures.
    Döpper S; Wilflingseder D; Prodinger WM; Stiegler G; Speth C; Dierich MP; Stoiber H
    Eur J Immunol; 2003 Aug; 33(8):2098-107. PubMed ID: 12884283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel approach to inhibit HIV-1 infection and enhance lysis of HIV by a targeted activator of complement.
    Xu Y; Zhang C; Jia L; Wen C; Liu H; Wang Y; Sun Y; Huang L; Zhou Y; Song H
    Virol J; 2009 Aug; 6():123. PubMed ID: 19671191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV and human complement: inefficient virolysis and effective adherence.
    Bánki Z; Stoiber H; Dierich MP
    Immunol Lett; 2005 Mar; 97(2):209-14. PubMed ID: 15752560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of complement receptors and regulatory proteins on alveolar CD4+ lymphocytes from human immunodeficiency virus-1 infected individuals.
    Aries SP; Schaaf B; Hansen F; Weyrich K; Kurowski V; Dennin R; Dalhoff K
    Eur Respir J; 1997 Aug; 10(8):1736-41. PubMed ID: 9272912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 and HIV-2 isolates differ in their ability to activate the complement system on the surface of infected cells.
    Marschang P; Gürtler L; Tötsch M; Thielens NM; Arlaud GJ; Hittmair A; Katinger H; Dierich MP
    AIDS; 1993 Jul; 7(7):903-10. PubMed ID: 7689323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function.
    Holers VM; Kinoshita T; Molina H
    Immunol Today; 1992 Jun; 13(6):231-6. PubMed ID: 1378280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells.
    Nielsen CH; Pedersen ML; Marquart HV; Prodinger WM; Leslie RG
    Eur J Immunol; 2002 May; 32(5):1359-67. PubMed ID: 11981823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry?
    Stoiber H; Frank I; Spruth M; Schwendinger M; Mullauer B; Windisch JM; Schneider R; Katinger H; Ando I; Dierich MP
    Mol Immunol; 1997; 34(12-13):855-63. PubMed ID: 9464521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation.
    Seya T; Hara T; Matsumoto M; Akedo H
    J Immunol; 1990 Jul; 145(1):238-45. PubMed ID: 1694203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
    Kuraya M; Yefenof E; Klein G; Klein E
    Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement C3 receptors: structure and function.
    Arnaout MA; Colten HR
    Mol Immunol; 1984 Dec; 21(12):1191-9. PubMed ID: 6240594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skin.
    Kirchhoff K; Weinmann O; Zwirner J; Begemann G; Götze O; Kapp A; Werfel T
    Immunology; 2001 Jun; 103(2):210-7. PubMed ID: 11412308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor I-mediated processing of complement fragments on HIV immune complexes targets HIV to CR2-expressing B cells and facilitates B cell-mediated transmission of opsonized HIV to T cells.
    Bánki Z; Wilflingseder D; Ammann CG; Pruenster M; Müllauer B; Holländer K; Meyer M; Sprinzl GM; van Lunzen J; Stellbrink HJ; Dierich MP; Stoiber H
    J Immunol; 2006 Sep; 177(5):3469-76. PubMed ID: 16920989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.